Loss of fused in sarcoma (FUS) promotes pathological Tau splicing

• Published in: EMBO reports Vol. 13; no. 8; pp. 759 - 764
• Main Authors: Orozco, Denise, Tahirovic, Sabina, Rentzsch, Kristin, Schwenk, Benjamin M, Haass, Christian, Edbauer, Dieter
• Format: Journal Article
• Language: English
• Published: Chichester, UK John Wiley & Sons, Ltd 01.08.2012; Nature Publishing Group UK; Blackwell Publishing Ltd; Nature Publishing Group
• Subjects: Amyotrophic lateral sclerosis; Animals; Axons - metabolism; Cytoskeleton; Cytoskeleton - metabolism; EMBO24; EMBO27; EMBO36; Exons - genetics; FUS; Gene Knockdown Techniques; Genes, Reporter; Growth Cones - metabolism; HEK293 Cells; Humans; Mice; Nerve Degeneration - genetics; Nerve Degeneration - pathology; neurodegeneration; Neurological disorders; Pathology; Phenotype; Physiology; Protein Binding; Protein Isoforms - genetics; Protein Isoforms - metabolism; Proteins; Rats; RNA Precursors - metabolism; RNA Splicing - genetics; RNA, Messenger - genetics; RNA, Messenger - metabolism; RNA-binding protein; RNA-Binding Proteins - metabolism; Sarcoma; Scientific Report; Scientific Reports; splicing; Tau (MAPT); tau Proteins - genetics; tau Proteins - metabolism; neurodegeneration; splicing; Tau (MAPT); FUS; RNA‐binding protein
• ISSN: 1469-221X; 1469-3178
• DOI: 10.1038/embor.2012.90

A subset of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) patients present pathological redistribution and aggregation of the nuclear protein fused in sarcoma (FUS) in the cytoplasm. Although FUS associates with the spliceosomal complex, no endogenous neuronal splicing targets have been identified. Here we identify Tau mRNA as a physiological splicing target of FUS. In mouse brain, FUS directly binds to Tau pre‐mRNA, and knockdown of FUS in hippocampal neurons leads to preferential inclusion of Tau exons 3 and 10. FUS knockdown causes significant growth cone enlargement and disorganization reminiscent of Tau loss of function. These findings suggest that disturbed cytoskeletal function and enhanced expression of the neurodegeneration‐associated Tau exon 10 might contribute to FTLD/ALS with FUS inclusions. Tau mRNA is identified as a splicing target of FUS in mouse brain. FUS silencing leads to inclusion of Tau exons 3 and 10, and phenocopies Tau loss‐of‐function, providing new insights into the generation of the neurodegenerative diseases ALS and FTLD.